Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Shares Outstanding (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Shares Outstanding for 4 consecutive years, with $7.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding rose 25.61% year-over-year to $7.2 million, compared with a TTM value of $7.2 million through Sep 2025, up 25.61%, and an annual FY2024 reading of $5.9 million, up 37.6% over the prior year.
  • Shares Outstanding was $7.2 million for Q3 2025 at Atara Biotherapeutics, up from $7.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $94.4 million in Q2 2022 and bottomed at $94879.0 in Q3 2022.
  • Average Shares Outstanding over 4 years is $16.6 million, with a median of $4.9 million recorded in 2024.
  • Peak annual rise in Shares Outstanding hit 4197.05% in 2023, while the deepest fall reached 95.87% in 2023.
  • Year by year, Shares Outstanding stood at $3.8 million in 2022, then grew by 10.97% to $4.3 million in 2023, then soared by 37.6% to $5.9 million in 2024, then grew by 23.06% to $7.2 million in 2025.
  • Business Quant data shows Shares Outstanding for ATRA at $7.2 million in Q3 2025, $7.0 million in Q2 2025, and $5.9 million in Q1 2025.